FDA issued a Warning Letter to McKesson Corporation Headquarters on 2/7/2019 as a result of this inspection.
FDA investigators audited the McKesson Headquarters - San Francisco, CA, United States facility and issued inspectional observations (via FDA 483) on 18 Jul 2018.
Add To Cart
- Category: Human Drugs
- Inspection end: 18 Jul 2018
- Location: San Francisco, United States
- FEI: 3014548060